Tanguamos, Gregorio H.
HRN: 27-29-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFTRIAXONE 1G (VIAL)
06/11/2025
06/18/2025
IV
2g
OD
Uti Complicated
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes